Standout Papers

Abuse and Misuse of Pregabalin and Gabapentin 2017 2026 2020 2023 279
  1. Abuse and Misuse of Pregabalin and Gabapentin (2017)
    Kirk E. Evoy, Stephen R. Saklad et al. Drugs

Immediate Impact

1 from Science/Nature 54 standout
Sub-graph 1 of 23

Citing Papers

Emerging challenges in antimicrobial resistance: implications for pathogenic microorganisms, novel antibiotics, and their impact on sustainability
2024 Standout
Pathology of pain and its implications for therapeutic interventions
2024 Standout
2 intermediate papers

Works of Kirk E. Evoy being referenced

Comparative-effectiveness of ceftaroline and daptomycin as first-line MRSA therapy for patients with sepsis admitted to hospitals in the United States Veterans Health Care System
2019
Abuse and Misuse of Pregabalin and Gabapentin
2017 Standout

Author Peers

Author Last Decade Papers Cites
Kirk E. Evoy 562 245 171 206 45 1.1k
Alyssa M. Peckham 510 256 135 143 37 956
Matthew Daubresse 728 342 135 255 25 1.2k
Jeanmarie Perrone 785 312 266 263 68 1.3k
Barbara Zedler 569 235 162 141 50 1.2k
Kelly S. Barth 469 225 64 260 46 1.1k
Jordan R. Covvey 384 159 70 103 72 1.1k
Jeffrey Gudin 514 378 94 158 55 1.1k
Peter M. Mullins 256 141 425 239 33 1.4k
Edgar H. Adams 541 415 68 192 30 1.3k
M. Schiller 697 256 89 331 24 1.3k

All Works

Loading papers...

Rankless by CCL
2026